Financials
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 17 M17 M18 M19 M17 M18 M 72 M Research & development —————— — Operating income 95 M83 M7 M65 M59 M-98 M 33 M Non-Operating Income, Total 22 M21 M21 M19 M20 M24 M 84 M Interest expense, net of interest capitalized 54 M53 M52 M53 M53 M51 M 209 M Non-Operating Income, excl. Interest Expenses -32 M-32 M-31 M-34 M-33 M-27 M -125 M Unusual income/expense —————— — Pretax income 59 M21 M-56 M-1 M-8 M-205 M -270 M Equity in earnings 28 M2 M—2 M02 M — Taxes -4 M-52 M1 M1 M6 M-1 M 7 M Non-controlling/minority interest 3 M7 M03 M2 M1 M 6 M After tax other income/expense 02 M———2 M — Net income before discontinued operations 54 M66 M57 M5 M16 M205 M 283 M Discontinued operations —————— — Net income 54 M66 M57 M5 M16 M205 M 283 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 53 M66 M58 M5 M16 M204 M 283 M Basic earnings per share (Basic EPS) 0.260.32-0.29-0.02-0.08-1.04 -1.43 Diluted earnings per share (Diluted EPS) 0.260.32-0.29-0.02-0.08-1.04 -1.43 Average basic shares outstanding 208 M207 M200 M199 M199 M199 M 797 M Diluted shares outstanding 210 M209 M200 M199 M199 M199 M 797 M EBITDA 548 M534 M467 M——— — EBIT 483 M466 M395 M——— — Cost of revenue 65 M57 M57 M——— — Other cost of goods sold 65 M57 M57 M——— — Depreciation & amortization (cash flow) 65 M68 M72 M123 M79 M71 M 345 M